|
111 Inc
YI's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into 111 Inc growth rates, revenue grew
by 7.43 % in IV. Quarter 2023 from the same quarter a year ago.
Ranking at No. 228
Pharmacy Services & Retail Drugstore industry recorded
growth of revenues by 12.33 %
111 Inc net loss decreased from $-55 millions, to $-50 millions in IV. Quarter 2023,
• More on YI's Growth
|
|
111 Inc realized a net loss in trailing twelve months.
111 Inc realized cash reduction of $ -0.08 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
26.65 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.42.
Pharmacy Services & Retail Drugstore industry's Price to Sales ratio is at 0.23.
• More on YI's Valuation
|
|
|
|
|
111 Inc realized net loss in trailing twelve months.
111 Inc realized cash outflow of $ -0.08per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
26.65 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.42.
Pharmacy Services & Retail Drugstore industry's Price to Sales ratio is at 0.23.
• More on YI's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com